ALL Backbone in AYAs

NCT07227584 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

67

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia
Philadelphia Chromosome-Negative Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia (ALL)
Leukemia

Interventions

DRUG: Blinatumomab
DRUG: Oncaspar
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Dexamethasone
DRUG: Doxorubicin Hydrochloride
DRUG: Etoposide
DRUG: Mercaptopurine
DRUG: Methotrexate
DRUG: Vincristine

Sponsor

Dana-Farber Cancer Institute